Argitalpenak (19) MARIA MERCEDES ALBERCA ZABALLOS argitalpenak

2023

  1. In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial

    Ophthalmology and Therapy, Vol. 12, Núm. 6, pp. 3251-3262

2021

  1. Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis

    Journal of Translational Medicine

  2. Treatment of Degenerative Disc Disease with Allogeneic Mesenchymal Stem Cells: Long-term Follow-up Results

    Transplantation

2020

  1. Bone regeneration with autologous adipose-derived mesenchymal stem cells: A reliable experimental model in rats

    MethodsX, Vol. 7

2019

  1. A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency

    Translational Research, Vol. 206, pp. 18-40

  2. Autologous bone marrow expanded mesenchymal stem cells in patellar tendinopathy: Protocol for a phase I/II, single-centre, randomized with active control PRP, double-blinded clinical trial

    Journal of Orthopaedic Surgery and Research, Vol. 14, Núm. 1

2017

  1. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial

    Transplantation, Vol. 101, Núm. 8, pp. 1945-1951

2015

  1. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: A randomized controlled trial

    Transplantation, Vol. 99, Núm. 8, pp. 1681-1690

2014

  1. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: Two-year follow-up results

    Transplantation

2013

  1. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: A pilot study

    Transplantation, Vol. 95, Núm. 12, pp. 1535-1541

2012

  1. Response to "overenthusiastic interpretations of a nonetheless promising study": Facts and opinions

    Transplantation

2011

  1. Intervertebral disc repair by autologous mesenchymal bone marrow cells: A pilot study

    Transplantation, Vol. 92, Núm. 7, pp. 822-828

2009

  1. Prospective comparative analysis of the angiogenic capacity of monocytes and CD1331 cells in a murine model of hind limb ischemia

    Cytotherapy, Vol. 11, Núm. 8, pp. 1041-1051

2007

  1. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression

    Transfusion and Apheresis Science, Vol. 37, Núm. 2, pp. 145-156

  2. Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers

    Cytotherapy, Vol. 9, Núm. 1, pp. 14-22

2006

  1. Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

    Blood, Vol. 107, Núm. 9, pp. 3575-3583

2005

  1. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors

    Haematologica, Vol. 90, Núm. 3, pp. 353-359

  2. Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability

    Experimental Hematology, Vol. 33, Núm. 8, pp. 935-943

2004

  1. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation

    Haematologica, Vol. 89, Núm. 12, pp. 1421-1427